Navigation Links
Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
Date:5/20/2011

p>

Overall rates of adverse events and serious adverse events were generally similar between XGEVA and Zometa. Osteonecrosis of the jaw (ONJ) was infrequent, with no statistically significant difference between treatment arms. Hypocalcemia was more frequent in the XGEVA treatment group. Overall survival and progression-free survival were similar between arms in all three trials.

XGEVA Regulatory Status

XGEVA is currently approved in the United States (U.S.) for the prevention of SREs in patients with bone metastases from solid tumors.  XGEVA was approved following a six month priority review by the U.S. Food and Drug Administration (FDA). In the U.S., XGEVA is not indicated for the prevention of SREs in patients with multiple myeloma.(i)   XGEVA is also approved in Canada for reducing the risk of developing SREs in patients with bone metastases from breast cancer, prostate cancer, non-small cell lung cancer, and other solid tumors.  In Canada, XGEVA is not indicated for reducing the risk of developing SREs in patients with multiple myeloma.

Amgen has also submitted marketing applications for XGEVA in Australia, Mexico, Russia and Switzerland. In Japan, Amgen is working with its licensing partner, Daiichi Sankyo Company, Limited and a marketing application was submitted in August. In addition, Amgen and GlaxoSmithKline (GSK) have a collaboration agreement for the commercialization of XGEVA in a number of countries where Amgen does not currently have a commercial presence. In these countries, marketing applications are filed by GSK.

XGEVA Important Safety Information

XGEVA can cause severe hypocalcemia. Correct pre-existing hypocalcemia prior to XGEVA treatment. Monitor calcium levels and administer calcium, magnesium, and vitamin D as necessary. Advise patients to contact a healthcare professional for symptoms of hypocalcemia.

ONJ can occur in patients receiving XGEVA. Patients who are
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
(Date:5/21/2013)... SAN DIEGO , May 21, 2013 /PRNewswire/ ... from a secondary analysis of its double-blind, randomized, ... CERE-120 is a gene therapy product designed to ... This exploratory analysis identified a more robust response ... years prior to treatment relative to those diagnosed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... 30 Although last year,s flu season was marked ... associated vaccine shortages, pharmacy experts at Cardinal Health expect ... 2010-2011 flu season. The upcoming 2010-2011 flu ... Advisory Committee on Immunization Practices (ACIP) has issued a ...
... YORK, Sept. 30 Reportlinker.com announces that a new market ... Drug Patent Inventor Report 2010 ... Report profiles the individuals, US states, and countries leading pharmaceutical ... to 2009, this report provides complete lists of: ...
Cached Medicine Technology:Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4Reportlinker Adds Drug Patent Inventor Report 2010 2
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... be at increased risk of suffering depression after giving ... hope they can use the findings to develop a ... are vulnerable to postpartum depression, which affects around 15 ... the May 21 issue of the journal Molecular ...
(Date:5/21/2013)... 2013 Pathways Home Health, Hospice ... to remember and honor a loved one in the ... Service, Sunday, June 2, 2013, 3-4 pm at Skylawn ... Mateo, CA 94402. , The Pathways Hospice Evening of ... program with music, readings and support. Open to the ...
(Date:5/21/2013)... patients are significantly more likely than their normal-weight ... practice that disrupts continuity of care and leads ... research suggests. , The practice of "doctor shopping" ... negative experiences with the health care system, whether ... weight loss advice by providers, or improperly sized ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... Diehard soccer fans will definitely want to ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English Premiere ... to the Busch Stadium, home of the St. Louis Cardinals, ... time that a professional sporting event and non-baseball game will ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2
... -- A reduction by half in the radiation dose ... imaging is now "feasible", according to an Israeli study. ... a late-breaking trial at the International Conference of Non-Invasive ... now one of the world,s major scientific events in ...
... Reporter , MONDAY, May 16 (HealthDay News) -- A new ... lowered ability to remember lists of words, although the research ... fine on a separate memory test. It,s not clear ... have any impact on the ability of college students to ...
... prostate cancer that measures levels of prostate specific antigen (PSA) ... of men with the disease was more sensitive and more ... a study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... rate of false-positives, tests that indicate the presence of cancer ...
... , MONDAY, May 16 (HealthDay News) -- In men who,ve ... smoking seems linked to a rise in blood levels of ... of cancer recurrence. So finds a new study slated ... American Urological Association (AUA) in Washington, D.C. The ...
... May 16 (HealthDay News) --,More than half of those who ... misdiagnosed when the first signs of the disease are symptoms ... researchers reviewed the cases of 40 people from Barcelona who ... also reviewed information about the age at which the symptoms ...
... by the Institute of Medicine explored what is necessary ... full potential of new digital technologies such as tablets ... knowledge to real-time care decisions. , Digital Infrastructure for ... in Health and Health Care recaps presentations and discussions ...
Cached Medicine News:Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 2Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 3Health News:Binge Drinking Tied to Memory Loss in College Students: Study 2Health News:New prostate cancer test more specific, sensitive than PSA test 2Health News:New prostate cancer test more specific, sensitive than PSA test 3Health News:Research Shows Early Onset Alzheimer's Disease Sometimes Missed 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: